APA (7th ed.) Citation

Korell, F., Sauer, S., Veelken, K., Hennemann, H. M., Schubert, M., Sauer, T., . . . Schmitt, A. (2020). Current challenges in providing good leukapheresis products for manufacturing of CAR-T cells for patients with relapsed/refractory NHL or ALL. Cells, 9(5), . https://doi.org/10.3390/cells9051225

Chicago Style (17th ed.) Citation

Korell, Felix, et al. "Current Challenges in Providing Good Leukapheresis Products for Manufacturing of CAR-T Cells for Patients with Relapsed/refractory NHL or ALL." Cells 9, no. 5 (2020). https://doi.org/10.3390/cells9051225.

MLA (9th ed.) Citation

Korell, Felix, et al. "Current Challenges in Providing Good Leukapheresis Products for Manufacturing of CAR-T Cells for Patients with Relapsed/refractory NHL or ALL." Cells, vol. 9, no. 5, 2020, https://doi.org/10.3390/cells9051225.